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1. Introduction 
Embryonic stem cells are pluripotent cells that, if cultured under specific conditions, give 
rise to clusters of beating cardiomyocytes. Beating cardiomyocytes, also dubbed beating 
areas, display gene expression profiles and functional properties similar to adult 
cardiomyocytes.  In line with this, a wide heterogeneity has been observed in embryonic 
stem cell-derived cardiomyocytes, resembling thus the distinct characteristics of atrial, 
ventricular and conductive cardiomyocytes.  
It has been recently demonstrated that two distinct cardiogenic precursor cells contribute to 
the developing heart. The first heart field contributes to the cardiac linear straight tube while 
a second population of cells adds cells to both arterial and venous pole of the cardiac tube, 
delimiting thus the second heart field. As cardiogenesis advances the first heart field mainly 
gives rise to the left ventricle, whereas the second heart field contributes to the right 
ventricle, outflow tract and the atrial chambers. A third population of cells, with distinct 
gene expression fingerprint has been demonstrated to form the inflow tract, suggesting the 
possible existence of a third heart field.  
Over the last years we have gained insights about the transcriptional mechanisms that 
govern the distinct heart fields, however, our understanding about if such endogenous 
program is recapitulated in embryonic stem cell-derived cardiomyogenesis remains elusive. 
Within this review we elaborate about the current state-of-the-art of the transcriptional 
networks that operate during embryonic stem cell-derived cardiomyogenesis, with special 
emphasis on the development of heart field transcriptional networks. 
2. Cardiogenic potential of embryonic stem cells 
Embryonic stem cells are pluripotent stem cells derived from the inner cell mass of the 
developing blastocyst. In vitro culture of embryonic stem cells, if nurtured under specific 
conditions, can give rise to distinct cell types of endodermal, mesodermal and ectodermal 
lineages, including thus beating cardiomyocytes (Miller-Hance et al. 1993). Such capabilities 
have raised the possibility of using embryonic stem cells as a source to heal the damaged 
heart (Chinchilla & Franco, 2006; Franco et al., 2007). However, several constrains has 
obstructed this purpose. Leaving apart ethical concerns, mainly applicable to human 
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embryonic stem cells, technical and scientific obstacles also have contributed to slow down 
this quest. We shall update in this book chapter the state-of-the-art progress made to 
conquer the challenging aim of converting embryonic stem cells into beating 
cardiomyocytes as suitable therapeutical tools. 
It is incredible to observe that a subset of cells hunted from the inner mass cells of the 
developing blastocyst, set in appropriate cell culture conditions, are able to progressively 
proceed in vitro, differentiating into neurons, fibroblasts, cardiomyocytes as well as in 
several other cells types (Lanza et al., 2004). The real question is then; does this occur 
mimicking the early step of embryogenesis? Several studies have demonstrated that upon 
the initial phases of in vitro embryonic stem cells culture, the aggregating cells that form the 
embryonic bodies in the hanging drops acquire a rather well organized three-dimensional 
structure, by which externally located cells express ectodermal markers, while internally 
located cells express mesodermal and endodermal makers (Doetschman et al., 1985, Wobus 
& Boheler, 1999; Boheler et al., 2002). Thus, these findings support the notion that cell 
specification and determination of embryonic stem cells into a discrete cell type would 
mainly follow the endogenous signal pathways. Therefore, in order to understand how stem 
cells can lead to cardiomyocytes, efforts should be made to learn the natural routing of a 
mesodermal cell that will contribute to the heart.  In essence we need to learn how cardiac 
development is achieved.  
3. Transcriptional control of cardiac muscle development 
Over the last two decades, our understanding of the cellular and molecular mechanisms that 
govern cardiac development has greatly advanced. Initial steps of mesoderm commitment 
from the lateral plate mesoderm to the forming heart are mainly directed by interplay 
between Bmp, Fgf and Wnt signaling (Barron et al., 2000; Lopez-Sanchez et al., 2002; 
Marques et al., 2008). As soon as the cardiogenic mesoderm is committed, several 
transcription factors, such as Nkx2.5, Gata4, Srf, Hand2 and Mef2c are activated, which play 
crucial roles during cardiogenesis as revealed by loss-of-function experiments in mice 
(Lyons et al., 1995; Srivastava et al., 1995; Kuo et al., 1997; Lin et al., 1997). Cardiogenesis 
proceeds by the formation of two concentrical tissue layers, an external myocardial and 
internal endocardial layer. To date it remains elusive how each cardiogenic lineage is 
distinctly established and whether they share a common progenitor (Linask & Lash, 1993; 
Eisenberg & Bader, 1995) or, on the contrary, they are distinctly derived from separate 
precursors (Cohen-Gould & Mikawa, 1996; Wei & Mikawa, 2000). As the myocardium is 
configured, it has been recently demonstrated that two distinct cell populations contribute 
to the developing heart; the first heart field (FHF) will contribute to the linear heart tube and 
subsequently will give rise mainly to the left ventricle (Kelly & Buckingham, 2002), whereas 
a second population of cells is subsequently recruited, namely the second heart field (SHF), 
contributing to the rest of the developing heart (Kelly et al., 2001; Cai et al., 2001; Waldo et 
al., 2001; Kelly & Buckingham, 2002).  FHF derivatives express Nkx2.5 but are negative from 
islet-1, while SHF cells express both Nkx2.5 and islet-1. In addition, SHF derivates can be 
subdivided in two distinct regions, according to their entry site to the developing heart; a) 
anterior SHF leads to the formation of the right ventricle and outflow tract, and its 
contribution is governed by signaling emanating from Fgf8- and Fgf10-expressing cells 
(Watanabe et al. 2010), as well as contribution from Tbx1 signaling at the 
arterial/pharyngeal pole of the heart (Huynh et al., 2007; Liao et al., 2008), b) posterior SHF 
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will contribute to the atrioventricular canal as well as right and left atria, and its 
contribution is directed by Fgf10 signaling at the venous pole of the heart (Kelly et al., 2001). 
In addition, complex regulatory networks are operative in the embryonic heart providing 
differentiation cues to the developing myocardium, as illustrated by the complex expression 
pattern of T-box genes, including therein Tbx2, Tbx3, Tbx5, Tbx18 and Tbx20 (Singh & 
Kispert, 2010; Greulich et al., 2011), Hand1 and Hand2 providing systemic vs pulmonary 
cues (Srivastava et al.,  1995; Thomas et al., 1995) as well as left/right positional cues as 
illustrated by Pitx2 (Franco & Campione, 2003; Chinchilla et al., 2011).  Thus, shared and 
distinct transcriptional pathways are governing first and second heart field deployment, 
leading in both cases to activation of a core cardiac transcriptional regulatory network as 
illustrated in Figure 1. 
In addition, a third population of cells, with distinct gene expression hallmark as compared 
to first and second heart field cardiac precursors, has been demonstrated to form the inflow 
tract of the heart, suggesting the possible existence of a third heart field (Mommersteeg et 
al., 2010). Nkx2.5 /islet-1 negative cells, but positive for Tbx18, contribute to the formation 
of the caval veins (Mommersteeg et al., 2010). However, recent Cre-based lineage tracing 
experiments have challenged this notion, since all myocardial component of the venous 
pole, including the atrial appendages and the caval and pulmonary veins, have been 
reported to be derived from  islet-1 and Nkx2-5 positive cells (Ma et al., 2008).   
Concomitant with the deployment of the first and second heart field precursor cells, 
differentiation into distinct cardiomyocyte cell types is occurring, providing thus distinct 
working chamber and conduction system myocardium. Tbx2 and Tbx3 have been reported 
to play a fundamental role controlling gene expression pattern within the atrioventricular 
node (Bakker et al., 2008; Aanhaanen et al., 2009, 2011). Shox2, Tbx3 and Tbx18 have been 
demonstrated to play a crucial role on the sinoatrial node formation (Hoogaars et al., 2007; 
Wiese et al., 2009; Espinoza-Lewis et al. 2009).  Furthermore, cardiomyocyte subtypes 
progressively emerge during cardiogenesis, such as distinct atrial and ventricular chamber 
myocardium, although the transcriptional regulation of such cell identities remains rather 
elusive. In chicken, Irx4 plays a crucial role in this step (Bao et al., 1999; Bruneau et al. 2000), 
however such function is not conserved in mice (Bruneau et al., 2001), which might be 
partially taken by Coup-tfII (Pereira et al., 1999; Wu et al., 2011). Similar events also are 
applicable for the cardiac conduction system, in which nodal and bundle branch fascicles 
are developed, each of them with distinct functional capabilities, yet their transcriptional 
regulation remains rather unexplored (Franco & Icardo, 2001; Miquerol et al. 2011).  
In the adult heart, some of the developmental differences are progressively smoothened, in 
such a way that we can consider the adult heart being composed of two types of working 
myocardium (atrial and ventricular) and three distinct types of conductive cells (SAN and 
AVN node, His and bundle branches, and Purkinje fibers). Curiously, novel transmural 
differences emerge in the adult ventricular myocardium (Yan & Antzelevitch et al., 1996, 
1999; de Castro et al., 2005), which are crucial for correct function of the heart (Constantini et 
al. 2005).  
In its important to highlight that during cardiogenesis, the heart is progressively acquiring 
novel functional capabilities, which are reflected on the progressive onset of expression of 
contractile, conductive and cytoskeleton proteins. At the contractile level, sarcomeric genes 
such as myosins, actins and troponins, and cytoskeleton proteins as tropomyosin and 
actinins are differently expressed already at early stages of development (Lyons et al., 1990; 
Franco et al., 1998) providing functional heterogeneity to the developing myocardium, as 
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Fig. 1. Schematic representation of embryonic cardiac development. At gastrulation, 
nascent precardiac mesoderm listens to signal emanating from the surrounding ectodermal 
and endodermal tissues, committing the cells into the cardiogenic lineage, i.e. cardioblasts. 
Cardioblasts are characterized by the expression of core cardiac transcription factors, 
including Nkx2.5, Gata4 and Mef2c. Soon thereafter, cardiomyocyte and endothelial cell 
lineages emerged and within the cardiomyocyte lineage, two distinct populations of cells 
can be recognized, first heart field (FHF) and second heart field (SHF) cells. A third 
population of cells is originating soon thereafter, which lacks Nkx2.5 or islet-1 expression, 
yet, lineage tracing evidences using Cre/LoxP system suggested they have had a common 
ancestry (Cai et al., 2003; Zhou et al., 2008). FHF contributes mainly to the left ventricle and 
the atrioventricular canal (AVC). AVC will eventually be remodeled as septation proceeds, 
contributing therein to the formation of the atrioventricular node, which is characterized by 
Tbx2 and Tbx3 expression. Interestingly, SHF have two distinct components, an anterior 
SHF contributing to the outflow tract and right ventricle, listing to signal emanating from 
the pharyngeal arches domain, such as Fgf8 and Fgf10, and a posterior SHF leading to the 
right and left atrial chambers, listing to signals such as Fgf10. The “third” heart field 
contributes to the sinous venosus, forming therefore the caval veins and the sinoatrial node, 
and to the pulmonary myocardium which constitutes the atrial septa and the pulmonary 
veins (Franco et al., 2000). Importantly, almost all previously mentioned cardiac lineages 
listen to left/right signaling clues provided by the homeobox transcription factor Pitx2 
(Campione et al., 1999; Franco & Campione, 2003). 
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detailed in Table 1. Similarly, ion channels and gap junctional proteins are progressively 
expressed in distinct regions of the developing heart (Gros & Jongsma, 1996; Franco et al. 
2001; de Castro et al., 2005)(Table 1), providing the bases for the onset of a persitaltoid 
contraction in first instance and subsequently of synchronous contraction at late embryonic 
stage, displaying thus an apex-to-base pattern of activation. In essence, if we take thus as a 
reference our knowledge about cardiac development, it sounds reasonable that such 
information could be applicable to embryonic stem cells in order to obtain beating 
cardiomyocytes.  
 
OFT RV LV AVC* RA SAN LA CV PV 
Transcription factors 
Mef2a                   
Mef2b                   
Mef2c                   
Mef2d                   
Hand1                   
Hand2                   
Tbx1                   
Tbx2                   
Tbx3                   
Tbx5                   
Tbx18                   
Tbx20                   
islet-1                   
Pitx2                   
Srf                   
Nkx2.5                   
Gata4                   
Gata5                   
Gata6                    
Sarcommeric proteins 
-cardiac actin                   
skeletal actin                   
sm-actin                   
mlc1a                   
mlc1v                   
mlc2a                   
mlc2v                   
-Mhc                   
-Mhc                   
c troponin I                   
sk troponin I                   
c troponin T                   
sk troponin T                   
a-tropomyosin                   
Ion channels 
Scn5a                   
Scn1b                   
Kcnq1                   
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OFT RV LV AVC* RA SAN LA CV PV 
Kcnh2                   
Kcne1                   
Kcne2                   
Kcne3                   
Kcne4                   
Kcne5                   
Kcnj2                   
Kncj4                   
Kcnj12                   
Kv4.2                   
Kv4.3                   
KChiP2                   
Hcn1                   
Hcn2                   
Hcn4                   
Gap junctions 
Cx40                   
Cx43                   
Cx45                   
Cx30.2                   
Others 
Nppa                   
Table 1. Graphical respresentation of the expression profiles of cardiac-enriched 
transcription factors, sarcomeric proteins, ion channels and gap junctional proteins during 
embryonic heart development, in distinct regions of the embryonic/fetal heart. OFT, 
outflow tract; RV, right ventricle, LV, left ventricle, AVC, atrioventricular canal, RA, right 
atrium, LA, left atrium, SAN, sinoatrial node, CV, caval veins, PV, pulmonary veins. *AVC 
will lead in the adult heart to the atrioventricular node.  
4. Understanding transcriptional control of in vitro cardiogenesis 
The formation of beating cardiomyocytes from undifferentiated embryonic stem cell has 
been an important focus of scientific research, as it can be witnessed by the number of 
publication in this front. Several of the signaling pathways involved in in vivo cardiogenesis 
are also recapitulated in vitro, as depicted in Figure 2. Importantly, initial reports provided 
evidences that embryonic stem cell-derived cardiomyocytes display morphological, 
molecular and functional characteristics similar to adult cardiomyocytes, displaying 
therefore expression of sarcomeric and gap junctional proteins (Sachinidis et al., 2003; van 
Kempen et al., 2003; Fijnvandraaf et al., 2003ab). Additional experiments, demonstrated that 
most ion channels that are natively configure the cardiac action potential are also expressed 
during embryonic stem cell-derived cardiomyocytes (van Kempen et al., 2003). Furthermore, 
elegant spatio-temporal studies also nicely illustrate the progressive onset of the core 
transcriptional cardiac and ion channel expression during embryonic stem cell-derived 
cardiomyogenesis (Fijnvandraaf et al., 2003ab, van Kempen et al., 2003). However, several 
caveats were soon arising. Firstly, the fact that embryonic stem cell cultures, although 
capable of providing a source of cardiomyocytes, yield on average to a low percentage 
(<20%). Secondly, beating areas display distinct contraction rates, suggesting that large 
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heterogeneity was observed from beating area to beating area, which might have gone 
unappreciated since most studies were done using RT-PCR methods. Thirdly, it was unclear 
if all cells within a beating area were equally differentiated. Sorting out these key questions 
is compulsory before any therapeutical strategy could be envisioned since a large number of 
cardiomyocytes is required, which will need to be morphologically homogeneous in order 
to avoid the chance of generating arrhythmias, and sufficiently and adequately 
differentiated in order to limit the oncogenic propagation of undifferentiated or poorly 
differentiated embryonic stem cells.  
 
 
Fig. 2. Schematic representation of the signaling pathways involved in embryonic stem 
cell–derived cardiogenesis.  Pluripotency makers such as Nanog, Oct4, Klf4 and Sox2 are 
expressed in undifferentiated embryonic stem cells. As soon as differentiation is initiated, 
these makers are down-regulated and mesoderm specification genes such as Mesp1 are 
expressed. Soon thereafter, as the beating areas are conformed, core cardiac transcriptional 
regulatory genes are up-regulated, and progressively the nascent cardiomyocytes acquire 
sacormeric and ion channel proteins, as depicted in Table 2.   
First approaches to increase the efficiency of converting embryonic stem cells into 
cardiomycytes has been obtained by mimicking the inductive signals that naturally convert 
precardiogenic mesodermal cells into nascent cardioblasts (Hidai et al., 2003; Holtzinger et 
al., 2010). Bin et al. (2006) demonstrates that Bmp2 treatment of mouse embryonic stem cells 
increased the efficiency of obtaining beating areas, providing evidences that core 
transcriptional factor Nkx2.5 and structural proteins such as troponin-T and alpha-MHC 
were increased. Further evidences on the pivotal role of Bmp signaling in embryonic stem 
cell-derived cardiomyogenesis were reported by Rajasingh et al. (2007). More recently, Kim 
et al. (2008) provides similar evidences using human embryonic stem cells. However, other 
authors have reported that Bmp2 overexpression can also lead to induction of other 
mesodermal lineages such as smooth muscle cells (Blin et al., 2010) or condroblasts,  
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OFT RV LV AVC* RA SAN LA CV PV 
Transcription factors 
Mef2a                   
Mef2b                   
Mef2c                   
Mef2d                   
Hand1                   
Hand2                   
Tbx1                   
Tbx2                   
Tbx3                   
Tbx5                   
Tbx18                   
Tbx20                   
islet-1                   
Pitx2 * * * *           
Srf                   
Nkx2.5                   
Gata4                   
Gata5                   
Gata6                    
Sarcommeric proteins 
-cardiac actin                   
skeletal actin                   
sm-actin                   
mlc1a                   
mlc1v                   
mlc2a                   
mlc2v                   
-Mhc                   
-Mhc                   
c troponin I                   
slow troponin I                   
fast troponin I                   
c troponin T                   
a-tropomyosin                   
Ion channels 
Scn5a                   
Scn1b                   
Kcnq1                   
Kcnh2                   
Kcne1                   
Kcne2                   
Kcne3                   
Kcnj2                   
Kncj4                   
Kcnj12                   
Kv4.2                   
Kv4.3                   
KChiP2                   
www.intechopen.com
 
Transcriptional Networks of Embryonic Stem Cell-Derived Cardiomyogenesis 159 
OFT RV LV AVC* RA SAN LA CV PV 
Hcn1                   
Hcn2                   
Hcn4                   
Gap junctions 
Cx40                   
Cx43                   
Cx45                   
Cx30.2                   
Others 
Nppa                   
 
Table 2. Graphical respresentation of the expression profiles of cardiac-enriched 
transcription factors, sarcomeric proteins, ion channels and gap junctional proteins during 
embryonic stem cell differentiation. ESC, embryonic stm cells, EB, embryoid bodies, BA2, 
beating areas at 2 days of culture, BA7, beating areas at 7 days of culture, EB14, beating 
areas at 14 days of cultures. 
osteoblasts and adipoblasts, if cultures with supplementary co-factors (zur Nieden et al., 
2005). Thus, these data suggest that combinatorial treatments might even further enhance 
embryonic stem cell-derived cardiomyogenesis. In this context, Evseenko et al. (2010) has 
elegantly evaluated the initial stages of mesoderm commitment during human embryonic 
stem cell differentiation, demonstrating the presence of endogenous cardiogenic 
morphogens such as activin A, Bmp4, Vegf and Fgf2. Laflamme et al. (2007) demonstrate 
that Bmp4 treatment increased in vitro cardiomyogenesis using human embryonic stem cells 
and Paige et al. (2010) has elegantly shown a balanced interplay between activin A/Bmp4 
and Wnt/-catenin is needed to efficiently induce mesodermal lineage formation and 
subsequent cardiomyocyte development in human embryonic stem cells. Similar findings 
are also observed using mouse embryonic stem cells (Taha et al., 2006, 2007; Taha & 
Valojerdi, 2008; Takei et al., 2009; Verma & Lenka, 2010). In addition to the role of Bmp 
signaling, several studies have reported the pivotal role of Fgf signaling controlling mouse 
embryonic stem cell-derived cardiomyogenesis (Dell´Era et al., 2003; Ronca et al. 2009). 
Importantly, Fgf signaling, in conjunction with Bmp signaling enhances cardiomyocyte 
formation of other stem cell sources, such as bone marrow stem cells (Degeorge et al., 2008) 
or P19 carcinoma cell line (Hidai et al., 2003), reinforcing the notion that Fgf signaling is 
necessary (embryonic stem cells) and sufficient (other sources) to induce cardiomyocyte 
development. Curiously, novel signaling pathways, such as Sdf-1/Cxcr4 (Chiriac et al., 
2010) and Vegf (Chen et al., 2006) also play a determinant role in cardiogenesis, although 
their links to Bmp, Fgf and Wnt signaling remains unexplored.  
Understanding of the embryonic stem cell-derived cardiomyogenesis has also been largely 
unraveled by manipulation of several cardiac enriched transcription factors. Gata4 and 
Gata6 deficient mice suggested a pivotal role of this transcription factor in early 
cardiogenesis (Kuo et al., 1997; Xin et al., 2006). Gata4 deficient embryonic stem cells have 
been reported to disrupt visceral endoderm formation and thus hematopoiesis (Soudais et 
al., 1995; Bielinska et al., 1996, 1997; Morrisey et al., 2000; Pierre et al., 2009). Similar findings 
are also observed in Gata6 deficient embryonic stem cells (Pierre et al., 2009). Importantly, 
cardiomyogenesis is not affected in Gata4 deficient embryonic stem cells (Narita et al., 1997) 
but over-expression of Gata4 in embryonic stem cells enhances cardiogenesis (Grepin et al., 
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1997) and visceral endoderm (Holtzinger et al. 2009) suggesting that Gata4 is not necessary 
but is sufficient to induce cardiomyocyte differentiation.  Nkx2.5 deficient mice display 
cardiac embryonic lethality (Lyons et al., 1995), supporting a pivotal role for Nkx2.5 in 
cardiomyogenesis. In this context, over-expression of Nkx2.5 in embryonic stem cells 
increases the expression of cardiogenic markers at the expenses of hematopoietic markers 
such as Gata-1 (Caprioli et al., 2011). Similarly, enhanced expression of Mef2c in embryonic 
stem cells increases cardiomyogenic differentiation (Puceat et al., 2003), in line with its 
determinant role during heart development as demonstrated by genetic deletion in mice 
(Lin et al., 1997). Comparable over-expression approaches in embryonic stem cells have been 
described for the homeobox transcription factor Pitx2, a left-right signaling pathway 
determinant (Campione et al., 1999, 2002). Enhanced expression of Pitx2 leads to increased 
expression of cardiac markers (Lozano-Velasco et al., 2011) supporting a role of this 
transcription factor in cardiogenesis. In addition, overexpression of Tbx5, a pivotal 
transcription factor associated with Holt-Oram syndrome (Li et al., 1997), in P19 embryonic 
carcinoma cells (Fijnvandraat et al., 2003abc) display similar findings.  Overall, these studies 
illustrate the pivotal role of distinct transcription factors with reported enhanced expression 
during cardiogenesis, as well as it also provides the entry to previously unknown 
transcription factors as key elements for cardiomyogenic lineage differentiation, as it is the 
case for the transcription factors hhLIM (Zheng et al., 2006) and Rb (Papadimou et al., 2005) 
or the GTPase Rac1 (Puceat et al., 2003).  
Importantly, although these reports provided evidence of enhancing cardiomyocte 
formation by the usage of discrete growth factors and/or transcription factors, and 
subsequently identifying cardiac specific molecular markers such as Nkx2.5, Gata4 and 
sarcomeric proteins (i.e troponin T and alpha-actinin), it remains elusive if cardiomyocyte 
heterogeneity in terms of lineage origin (FHF, SHF), gene expression (atrial/ventricular/ 
nodal) or function (working/conductive) is observed. We have recently reported that mouse 
embryonic stem cell-derived cardiomyocytes display a dynamic temporal expression of FHF 
and SHF makers which are reminiscent of the in vivo cell lineage deployment (Lozano-
Velasco et al. 2011). In addition, large heterogeneity in gene expression, displaying distinct 
atrial-, ventricular- and nodal-like patterns (Fijnvandraat et al. 2002, 2003abc) and functional 
heterogeneity (van Kempen et al., 2003) displaying distinct cardiac action potential 
configurations, have been extensively reported. In this context, is it important to highlight 
that overexpression of Pitx2 mainly directs the expression of SHF cardiomyocytes, since 
both islet-1 and Mef2c were up-regulated, whereas FHF marker Nkx2.5 was unaltered 
(Lozano-Velasco et al., 2011).  Furthermore overexpression of Pitx2 enhances Tbx5 
expression and thus Nppa (Anf) and Gja5 (Cx40)(Lozano-Velasco et al., 2011), in line with 
previous Tbx5 over-expression findings (Fijnvandraaf et al., 2003). Thus, it is plausible that 
enhance cardiomyocyte commitment by distinct inductive signals might generate cellular 
heterogeneity in a similar fashion as in the developing heart. If so, these observations might 
hindrance their therapeutical usage since,  for example, engrafting nodal-like cells in the 
ventricular chambers might lead to ectopic electrical foci and thus to arrhythmias.  In this 
context, searching for transcriptional factor cocktail which might homogenize the 
cardiomyocyte outcome is a plausible strategy, as recently reported to convert induced 
pluripotent fibroblasts into cardiomyocytes (Ieda et al. 2010) or hepatocytes (Huang et al., 
2011).  
Differentiation of embryonic stem cells into beating cardiomyocytes can therefore be naively 
observed by simply developing embryoid bodies or enhanced by supplementing these 
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embryonic stem cells and/or embryoid bodies with a subset of growth factors and/or 
transcription factors. Table 2 summarizes the current state of the art knowledge about the 
dynamic expression of distinct transcription factors, sarcommeric proteins, ion channels and 
gap junctions during embryonic stem cell-derived cardiomyogenesis. However, the question 
arising is: are all beating areas differentiated into cardiomyocytes or are there remaining 
non-differentiated embryonic stem cells or contaminating cells that might differentiate into 
other embryonic lineages? This is a crucial question if we aim to use them in vivo. We have 
recently reported that fine-dissection of beating areas have minor contamination of 
endodermal- or ectodermal cells (Lozano-Velasco et al., 2011) at distinct developmental 
stages. Thus, it seems that a rather homogeneously differentiated cluster of cells is normally 
achieved. It remains to be elucidated if undifferentiated embryonic stem cells remain in 
those areas. In vivo approaches suggest that indeed this might be the case, yet titering the 
number of engrafted cells results in absence of teratomas at the long run (Behfar et al., 2005, 
2007; Yamada et al. 2009).  
5. Conclusions and perspectives 
Over the last decade we have started to understand the molecular mechanisms that govern 
cardiac formation and we are translating these findings to the manipulation of embryonic stem 
cells opening promising avenues to enhance cardiomyocyte differentiation. We have learnt 
how to increase the number of cardiomyocyte produced, and we have learnt that embryonic 
development is faithfully recapitulated in vitro, including the onset of first and second heart 
field transcriptional programs. Manipulation of these transcriptional machinaries will be 
therefore the upcoming challenges for the next years to come in order to facilitate the 
generation of fully differentiated, structurally similar and functionally homogeneous 
cardiomyocytes. Searching for transcription factor cocktails or opening new strategies such as 
those emerging from the microRNA world (Ivey et al. 2008; Chinchilla et al., 2011) constitutes 
the next goals, as recently illustrated for miR-499 (Wilson et al., 2010). Thus, in summary, an 
important part of the route has been walked, and the way ahead seems promising with the 
reward of achieving therapeutically usable embryonic stem cell-derived cardiomyocytes. 
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